February 14, 2022
To whom it may concern
Company name: Nihon M&A Center Holdings Inc.
Representative: Suguru Miyake, President and Representative Director
(Sto ck exch an ge cod e: 2 12 7 , TSE First Section)
Contact: | Takamaro Naraki, |
Senior Managing Director, General | |
Manager, Administration Division | |
(Phone: +81-3-5220-5451) |
Announcement regarding submission of the report on restatements and the impact of restatements on
published financial accounts
On December 20, 2021, Nihon M&A Center Holdings Inc. (the "Company") issued a statement "Announcement of Investigation on Attribution Period of Sales at its Subsidiary" concerning the discovery of some erroneous apportionment of sales to accounting periods at its subsidiary Nihon M&A Center Inc., since when the Company has been investigating what actually occurred.
Consequently on February 14, 2022, the Company is issuing a statement "Announcement regarding receipt of the Research Committee Investigation Report and publication of its findings" which outlines the decision to issue restatements of prior year published financial reports, which are summarised below along with the consequent revisions to its prior year financial statements.
The Company again profusely apologises for the huge trouble and concern this has caused its shareholders, the investment community and related parties.
Details
1.Revision Announcement to be released today concerning prior year reported financial statements
(1) | Revision Announcement concerning prior year reported financial securities report | |||
Period 30 Year end March 2021 | Financial Securities Report(April 1, 2020 - March 31, 2021) | |||
(2) | Revision Announcement concerning prior year quarterly securities reports | |||
Period 31 Year end March 2022 | Q2 | Securities Report(July 1, 2021 - September 30, 2021) | ||
Period 31 Year end March 2022 | Q1 | Securities Report(April 1, 2021 - June 30, 2021) | ||
Period 30 | Year end March 2021 | Q3 | Securities Report(October 1, 2020 - December 30, 2020) | |
Period 30 | Year end March 2021 | Q2 | Securities Report(July 1, 2020 - September 30, 2020) | |
Period 30 | Year end March 2021 | Q1 | Securities Report(April 1, 2020 - June 30, 2020) | |
(3) | Announcement of prior year internal control report revision | |||
Period 30 | Year end March 2021 | Internal Control Report (April 1, 2020 - March 31, 2021) |
2.Reasons for restatements
In the process of accounting for its sales it became apparent that there had been inaccurate internal reporting in prior years and an internal investigation was carried out, as a result of which it was discovered that there had been a suspected breach of internal compliance rules with inappropriate behaviour by certain employees. Consequently the Company formed a Research Committee including external legal and accounting experts for further investigation.
The consequent report received from the Research Committee on February 14, 2022 showed that among the debtors recorded since April 2016 there were xx cases of inaccurate apportionment to sales having occurred since April 2018.
Accordingly the Company elected to revise the relevant sections of the previously reported financial statements
showing consolidated and non-consolidated financial information, along with the quarterly financial reports.
These revisions necessitate the need to adjust figures, starting with those released on November 12, 2021 for Q2 of Period 31 (July1, 2021 to September 30, 2021), deemed to be material according to Article 24 section 4- 7-4 of the Financial Instruments and Exchange Act and thereby triggering publications of revisions to quarterly reports.
3.The financial impact of revisions to prior year results
The principal component of the revision is inaccurate apportionment of sales, which necessitates quarterly restatements of all related items. The table below specifies the financial impact on its prior year results.
【Consolidated financial statements】 | (JPYm) | ||||
Period | Item | Reported | Restated | Adjustment | Change |
(A) | (B) | (B-A) | (%) | ||
Period 31 | Sales | 32,938 | 34,273 | 1,335 | 4.1% |
(Year to March 2022) | Operating profit | 14,459 | 15,541 | 1,082 | 7.5% |
9 months to December | Ordinary profit | 14,560 | 15,643 | 1,082 | 7.4% |
(※ Announced today) | Net profit attributable | ||||
to shareholders in the | 9,750 | 10,502 | 751 | 7.7% | |
period | |||||
Total assets | 58,146 | 58,130 | △16 | △0.0% | |
Net assets | 50,251 | 50,266 | 14 | 0.0% | |
Period 31 | Sales | 23,634 | 23,420 | △214 | △0.9% |
(Year to March 2022) | Operating profit | 11,800 | 11,548 | △251 | △2.1% |
6 months to September | Ordinary profit | 11,793 | 11,541 | △251 | △2.1% |
Net profit attributable | |||||
to shareholders in the | 7,996 | 7,821 | △174 | △2.2% | |
period | |||||
Total assets | 60,239 | 58,518 | △1,721 | △2.9% | |
Net assets | 51,199 | 50,287 | △911 | △1.8% | |
Period 31 | Sales | 11,613 | 11,727 | 114 | 1.0% |
(Year to March 2022) | Operating profit | 5,854 | 5,806 | △47 | △0.8% |
3 months to June | Ordinary profit | 5,807 | 5,760 | △47 | △0.8% |
Net profit attributable | |||||
to shareholders in the | 3,928 | 3,895 | △32 | △0.8% | |
period | |||||
Total assets | 54,425 | 53,065 | △1,359 | △2.5% | |
Net assets | 46,964 | 46,194 | △769 | △1.6% | |
Period 30 | Sales | 36,130 | 34,795 | △1,335 | △3.7% |
(Year to March 2021) | Operating profit | 16,408 | 15,336 | △1,072 | △6.5% |
Full year | Ordinary profit | 16,540 | 15,468 | △1,072 | △6.5% |
Net profit attributable | |||||
to shareholders in the | 11,415 | 10,678 | △736 | △6.5% | |
period | |||||
Total assets | 55,558 | 54,110 | △1,448 | △2.6% | |
Net assets | 45,427 | 44,690 | △736 | △1.6% | |
Period 30 | Sales | 28,424 | 27,832 | △592 | △2.1% |
(Year to March 2021) | Operating profit | 14,170 | 13,637 | △533 | △3.8% |
9 months to December | Ordinary profit | 14,188 | 13,655 | △533 | △3.8% |
Net profit attributable | |||||
to shareholders in the | 9,798 | 9,428 | △369 | △3.8% | |
period | |||||
Total assets | 52,782 | 52,131 | △651 | △1.2% | |
Net assets | 43,728 | 43,359 | △369 | △0.8% | |
Period 30 | Sales | 18,781 | 18,363 | △418 | △2.2% |
(Year to March 2021) | Operating profit | 9,775 | 9,430 | △345 | △3.5% |
6 months to September | Ordinary profit | 9,768 | 9,423 | △345 | △3.5% |
Net profit attributable | |||||
to shareholders in the | 6,763 | 6,524 | △239 | △3.5% | |
period | |||||
Total assets | 52,557 | 52,097 | △460 | △0.9% | |
Net assets | 42,873 | 42,633 | △239 | △0.6% | |
Period 30 | Sales | 9,089 | 8,868 | △221 | △2.4% |
(Year to March 2021) | Operating profit | 4,887 | 4,713 | △173 | △3.6% |
3 months to June | Ordinary profit | 4,876 | 4,703 | △173 | △3.6% |
Net profit attributable | |||||
to shareholders in the | 3,345 | 3,225 | △120 | △3.6% | |
period | |||||
Total assets | 44,071 | 43,828 | △243 | △0.6% | |
Net assets | 37,013 | 36,892 | △120 | △0.3% |
- Revised figures for the nine months to December 2022 take into account the findings of the investigation and are as reported today in the financial report for the third quarter of the year to March 2022.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Nihon M&A Center Inc. published this content on 14 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 February 2022 06:31:59 UTC.